Brunistill Ketotifen eye drops 0.5ml 0.025mg 20 Single dose
- Brand: BRUSCHETTINI Srl
- Product Code: 037448026
- EAN:
- Availability: In Stock (evaso in 24 ore)
- 3 items
for 14,26€ each - 4 items
for 13,97€ each - 5 items
for 13,68€ each
Brunistill Single-dose eye drops Ketotifen 0.5ml 0.025mg
Therapeutic indications
BRUNISTILL eye drops is indicated in the symptomatic treatment of seasonal allergic conjunctivitis, thanks to its mix of active ingredients it is able to counteract the phenomenon of conjunctivitis.
Composition of Brunistill Eye Drops
A single-dose container of 0.5 ml of solution contains: Active ingredient: ketotifen 125 mcg (as hydrogen fumarate), equal to 250 mcg / ml For excipients see 6.1.
Excipients
Glycerol (E422) Sodium Hydroxide Purified water.
Contraindications
Hypersensitivity to the active substance ketotifen or to any of the excipients listed in section 6.1.
Dosage and method of use of Brunistill Collirio
Adults, the elderly and children (over 3 years): one drop of eye drops in the conjunctival sac twice a day. The content of a single-dose container is sufficient for one administration in both eyes. Contents and container remain sterile until the original closure is opened. To avoid the risk of contamination, do not touch any surface with the tip of the container.
Warnings and Precautions
No special precautions
Interactions
If you are using other medications for ocular use, you should leave at least 5 minutes between applications. Oral administration of ketotifen may potentiate the effects of CNS depressant drugs, antihistamines and alcohol. Although these phenomena have not been observed with BRUNISTILL, the possibility of such effects cannot be excluded.
Side effects
The following undesirable effects have been reported at the recommended dose. The frequency listed below is defined using the following convention: very common (≥1 / 10), common (≥1 / 100 to <1/10), uncommon (≥1 / 1000 to <1/100), rare (≥1 / 10,000 to <1 / 1,000).
MedDRA system organ classification | Adverse events | Frequency |
Eye disorders: | eye irritation, eye pain, punctate keratitis. | common |
blurred vision (during instillation), dry eye, eyelid disorders, conjunctivitis, photophobia, conjunctival hemorrhages. | Uncommon | |
Nervous system disorders: | headache | Uncommon |
General disorders and administration site conditions | drowsiness | Uncommon |
Skin and subcutaneous tissue disorders: | rash, eczema, urticaria | Uncommon |
Gastrointestinal disorders: | dry mouth | Uncommon |
Immune system disorders: | hypersensitivity | Uncommon |
Pregnancy and breastfeeding
No clinical data are available on the use of BRUNISTILL in pregnancy. Animal studies with toxic oral doses have shown an increase in pre- and postnatal mortality, but have not shown teratogenic effects. Systemic levels of ketotifen after ophthalmic application are much lower than those achieved after oral administration. However, caution should be exercised when prescribing the medicine to pregnant women. Although data from consecutive animal studies with oral administration demonstrate excretion of the active substance in breast milk, topical administration in women is unlikely to produce detectable quantities of the active substance in breast milk. Mothers using BRUNISTILL eye drops can therefore breastfeed.
Packaging and storage
The product is sold in packs of 20 single-dose solutions, it is important to keep Brunistill Collirio in a dry place away from sources of heat and humidity, keep out of reach of children.